Cutting edge liver health management program

Best practices for revitalizing liver

Practice impact calculator

Our Healthy Program

Find out more about the program, its outcomes and the benefits it has provided to patients and physicians.

watch the video

Check out our recommended articles

Obesity Has Reached Crisis Proportions

Understanding the Alarming Scale of the Obesity Problem

Latest NAFLD Practice guidelines by AGA

Clinical care Pathway for the risk stratification and management of patients with NAFLD

A Liver Scan on the Drive-Thru Menu?

Non-invasive liver tests track lifestyle changes for better liver health

Expanding Benefits in FibroScan® Use and Integrating Digital Tools

Navigating the Future of Liver Health: FibroScan®, Data Integration, and Patient Care

Meet us at these upcoming events

08-09

MAR

Emerging Topic Conference: Precision Medicine in MASLD

Las Vegas, Nevada

Learn about AASLD's upcoming Emerging Topic Conference being held at the Four Seasons in Las Vegas, on Precision Medicine in MASLD.

05-08

JUN

EASL Congress 2024

Milan, Italy

Europe's biggest hepatology event, EASL Congress 2024, unites 7,000+ professionals in Milan (and online) for 4 days of learning, networking & research sharing. Join world-class faculty & shape the future of liver disease care!

Today 25-30% of the general population are estimated to have NAFLD, most being undetected. With the expected rise of NAFLD prevalance by 2030, NASH is projected to DOUBLE.

Current clinical guideliness recommend:A NAFLD screening should be part of a routine work-up in high-risk patients! Patients having Type 2 diabetes, obesity, and/or metabolic syndrome.

Two Companies, One Mission

Providing a complementary approach to managing and monitoring

chronic liver deseases, which may lead to improve patient outcomes.

Innovation dedicated to liver health, offering FibroScan®,

the leading non-invasive liver testing solution.

The leader in digital therapeutics providing a scalable

NAFLD clinical service line.